|
impaired liver function, plump fuck , plump girls galleries , immunization, refsum disease, poynard, plump buttocks , liverdisease, plump djs , iv drugs, plump teens , steatosis, sirrohsis, roferon a, pictures of fat girls , health news, pegasys combination therapy, fibrotest, hepatomegaly, jaundice,
|
Condition Intervention Phase HIV InfectionsNon-Alcoholic Fatty Liver Disease Drug: antioxidant vitamin E, betaine Behavior: weight reduction and exercise Phase II MedlinePlus related topics: AIDS nonalcoholic fatty liver diseasee symptoms Study Type: InterventionalStudy Design: Treatment, Randomized, Open Label, Placebo Control, Single Group Assignment Official Title: Non-Alcoholic Fatty Liver Disease (NAFLD) in HIV: The Role of Nutritional Interventions Further study details as provided by University Health Network, Toronto: Primary Outcomes: The change nonalcoholic fatty liver diseasee symptoms in grading of inflammation assessed by liver biopsy from month 0 to month 12 of the studySecondary Outcomes: liver histology for steatosis and fibrosis staging; liver immuno-histochemistry for adducts fo MDA; a product of LP; alpha-smooth muscle actin (alpha-SMA); a marker of hepatic stellate cell activation; transforming growth factor (TGF-beta); a profibrogenic cytokine involved in fibrogenesis; liver lipid peroxides and TNP-alpha; liver steatosis and volume will be assessed by ultrasound; liver enzymes and IR (HOMA and QUICKLY) will also be measured; INF-alpha; lipid peroxide, vitamin E and C will aslo be measured in the plasma Expected Total Enrollment: 90 Study start: October 2003 Eligibility Ages Eligible for Study: 18 Years and above, Genders Eligible for Study:
|
